5.0
19 Aug 2020
Current employee, less than 1 year
Paris
Recommend
CEO approval
Business outlook
Pros
Very dynamic and leader in the segment
Cons
Don't spend as much as big pharma but that's part if the business model
Check out your Company Bowl for anonymous work chats.